Fluoroquinolones have safety concerns that limit their use in certain people and require specific counseling. They can cause tendinopathy and tendon rupture, especially in older adults and when combined with steroids, so patients should be told to report tendon pain or swelling and to discontinue the drug if this occurs. They can prolong the QT interval, which raises the risk of serious arrhythmias in people with baseline QT prolongation, electrolyte disturbances, or those taking other QT-prolonging drugs; this means assess heart rhythm risk and be cautious in those individuals. They are generally avoided in pregnancy and in children because of potential effects on developing cartilage and joints. They interact with multivalent cations—antacids, iron, calcium, magnesium, zinc, and sucralfate—which can bind the drug and reduce absorption, so dosing should be separated by several hours around these products. They also can cause phototoxicity, so patients should minimize sun exposure and use protective clothing or sunscreen. For counseling, review risk factors, instruct on separating administration from antacids/minerals, warn about tendon symptoms and sunlight sensitivity, and monitor for signs of QT-related issues or other adverse effects, with alternatives considered if these risks outweigh benefits.

Brand names are marketing identifiers created by the company that develops and sells the drug. They are typically trademarked names chosen to be memorable and marketable, helping clinicians and patients recognize the product. Regulatory bodies don’t assign these brand names; they review the drug for safety and efficacy and may approve the generic (nonproprietary) name, but the actual brand name is a business decision made by the manufacturer. The clinician or patient may use the brand name in conversation, but neither dictates the brand name's creation. For example, a drug with the generic name acetaminophen might be sold under the brand name Tylenol by the manufacturer, while ibuprofen might appear under a different brand name like Advil. The same medication can have multiple brand names across different companies and regions, all tied to the manufacturer’s branding rather than a regulatory assignment.

Photosensitivity from antibiotics occurs when a drug makes the skin more reactive to UV light, leading to sunburn-like reactions after sun exposure. This effect is most commonly seen with fluoroquinolones. Meds in this class, such as ciprofloxacin and levofloxacin, can cause redness, itching, and even blistering on sun-exposed skin after only brief exposure. Because of this risk, patients taking these antibiotics should take sun-protection steps: use broad-spectrum sunscreen, wear protective clothing and hats, seek shade, and avoid tanning beds. If a severe skin reaction develops, contact a clinician promptly. Other antibiotic classes listed are less likely to cause photosensitivity, so the sun-protection emphasis is specifically important with fluoroquinolones.

Naloxone is used because opioids depress respiration by activating mu receptors, and naloxone acts as a competitive antagonist at those same receptors, rapidly displacing the opioid and reversing the respiratory depression and sedation. The key nursing priority during administration is to monitor breathing and vital signs closely and to titrate naloxone to restore adequate respiration while avoiding overshoot that could cause withdrawal or agitation. Watch blood pressure and heart rate, since naloxone can provoke autonomic changes. Be prepared for re-dosing or an infusion because the opioid’s effects may outlast the antidote, leading to return of respiratory depression or pain. Ensure airway support and have resuscitation equipment ready, and monitor for withdrawal symptoms in opioid-dependent patients, which can include agitation, tachycardia, hypertension, nausea, and vomiting. Other options don’t fit as the acute antidote: activated charcoal doesn’t reverse opioid effects, flumazenil targets benzodiazepines and can trigger seizures, and naltrexone is used for long-term opioid dependence or prevention, not for acute overdose and can affect hepatic function.